comparemela.com

Latest Breaking News On - Luke miels - Page 2 : comparemela.com

Analysts tip label expansion to bolster GSK's hand in RSV fight

Analysts tip label expansion to bolster GSK's hand in RSV fight
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Luke-miels
European-medicines-agency
Pfizer
Advisory-committee-on-immunization-practices
Advisory-committee
Immunization-practices

GSK plc (NYSE:GSK) Q4 2023 Earnings Call Transcript

GSK plc misses on earnings expectations. Reported EPS is $0.72 EPS, expectations were $0.76.

China
Luke-miels
Emma-walmsley
Nick-stone
Glaxosmithkline-plc
Call-transcript-january
Consumer-healthcare
Global-corporate-sustainability
Corrupt-countries
Specialty-medicines
General-medicine

GSK sales of RSV vaccine stay strong, beating forecast

BioPharma

Japan
Luke-miels
Drug-administration
Pfizer
Wall-street
Pharma

RSV vaccine market needs a 'slow build' approach, but we can create consistent vax compliance: GSK

RSV vaccine market needs a 'slow build' approach, but we can create consistent vax compliance: GSK
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-states
Americans
Emma-walmsley
Luke-miels
Pfizer
Healthcare-conference
Chief-commercial-officer-luke-miels

GSK to buy asthma drug developer for up to $1.4 billion in pipeline push

The British pharmaceutical giant's deal will give it access to Aiolos' AIO-001 asthma treatment

San-francisco
California
United-states
China
United-kingdom
Chinese
British
Bristol-myers-squibb
Aiolos-bio
Luke-miels
Bain-capital-life-sciences
Jiangsu-pharmaceutical-co

vimarsana © 2020. All Rights Reserved.